Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?

In recent decades, very few new psychiatric drugs have entered the market. Thus, improvement in the use of antidepressant and antipsychotic therapy has to focus mainly on enhanced and more personalized treatment with the currently available drugs. One important aspect of such individualization is em...

Descripción completa

Detalles Bibliográficos
Autores principales: van Westrhenen, Roos, Aitchison, Katherine J., Ingelman-Sundberg, Magnus, Jukić, Marin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080976/
https://www.ncbi.nlm.nih.gov/pubmed/32226396
http://dx.doi.org/10.3389/fpsyt.2020.00094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080976/
https://www.ncbi.nlm.nih.gov/pubmed/32226396
http://dx.doi.org/10.3389/fpsyt.2020.00094

Ejemplares similares